Advances in the management of Crohn's disease: economic and clinical potential of infliximab
- 1 September 1998
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 20 (5) , 1009-1028
- https://doi.org/10.1016/s0149-2918(98)80082-9
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Crohn's disease in Olmsted County, Minnesota, 1940–1993: Incidence, prevalence, and survivalGastroenterology, 1998
- An evaluation of utility measurement in Crohn's diseaseInflammatory Bowel Diseases, 1997
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 1996
- Role of the neuroendocrine system in cytokine pathways in inflammatory bowel disease.Alimentary Pharmacology & Therapeutics, 1996
- Quality of Life in Inflammatory Bowel Disease and Other Chronic DiseasesScandinavian Journal of Gastroenterology, 1996
- NEW THERAPEUTIC APPROACHESGastroenterology Clinics of North America, 1995
- Cytokines in intestinal inflammation: Pathophysiological and clinical considerationsGastroenterology, 1994
- Inflammatory Bowel DiseaseJournal of Clinical Gastroenterology, 1992
- EPIDEMIOLOGY OF INFLAMMATORY BOWEL DISEASEEpidemiologic Reviews, 1986
- Anal complications in Crohn's diseaseDiseases of the Colon & Rectum, 1981